Special Contributing Faculty
Faculty members who do not serve as dissertation mentors but who make contributions to the education of our students by teaching or serving as clinical mentors are appointed as Gerstner Sloan-Kettering Special Contributing Faculty.
The following is a list of current members of the contributing faculty along with their research interests:
Epidemiology and Biostatistics
Hierarchical models in genetic association studies, misspecification tests, and survival analysis.
Paul B. Chapman
Mechanisms by which the immune system recognizes cancer and the development of effective immunotherapy treatments.
Maura N. Dickler
Hormonal therapy and anti-angiogenic therapy of breast cancer.
Clifford A. Hudis
Translational clinical trials for breast cancer.
Joseph G. Jurcic
Acute myeloid leukemia, monoclonal antibodies, and radioimmunotherapy.
Molecular imaging of cancer by PET, hypoxia, and targeted radionuclide therapies, especially with tumor-specific antibodies.
Cancer Biology & Genetics
Identification of genes responsible for inherited predisposition to cancer.
David S. Klimstra
Pathology of pancreatic, hepatobiliary, and gastrointestinal neoplasia.
Mark G. Kris
Medicine|Clinical trials and translational research.
Robert J. Motzer
Clinical trials for metastatic renal cell carcinoma and germ cell tumors.
Breast Cancer clinical trials, tumor growth kinetics, and mathematics of metastasis.
Philip B. Paty
Biomarkers — diagnostic, prognostic, predictive — for colorectal cancer.
Victor E. Reuter
Marker evaluation and validation in urologic cancers.
Development of new therapies for colorectal cancer.
Howard I. Scher
Mechanism-based drug development for prostate cancer.
Genomics: from microarrays to next generation sequencing.
Molecular Pharmacology & Chemistry
Analytical pharmacology/toxicology, bioassay, and drug-delivering technology.
Nuclear medicine and molecular imaging research: hypoxia imaging, targeted radionuclide therapy, and small-animal imaging.
Andrew D. Zelenetz
Clinical and translation research in lymphoma.
Magnetic resonance imaging and spectroscopy to study cancer.